Telemedicine Management of Chronic Insomnia (VIP)
Telemedicine Management of Veterans With PTSD and Chronic Insomnia
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Objectives(s): The investigators are conducting a randomized, controlled trial of Veterans with PTSD and chronic insomnia to determine if cognitive behavioral therapy for insomnia (CBT-I) administered by video teleconferencing is not clinically inferior to in-person treatment in terms of improvement in insomnia symptoms. Secondary aims are 1) comparing the differences in cost and quality-adjusted life years between the treatment delivery approaches and 2) determining the effectiveness of CBT-I on functional outcomes, sleep quality, and non-sleep-related PTSD symptoms. The investigators are also conducting a patient- and provider-focused formative evaluation of CBT-I delivery by video teleconferencing to assess potential barriers to its widespread implementation.
Research Design: This prospective randomized controlled non-inferiority study will determine if Veterans with PTSD and chronic insomnia receiving CBT-I by video teleconferencing have an improvement in insomnia severity, as determined by change in Insomnia Severity Index (ISI) score, that is not clinically inferior to that in Veterans receiving in-person CBT-I. Differences in cost and quality-adjusted life years (QALY) between groups will also be compared.
Methodology: Veterans with PTSD and chronic insomnia receiving their primary care at community-based outpatient clinics (CBOC) affiliated with the Philadelphia VAMC are be randomized to receive one of the following interventions in a group setting at their CBOC: 1) a manual-based CBT-I program delivered via video teleconferencing, 2) the CBT-I program delivered in-person, and 3) in-person delivery of sleep hygiene education, a known active control intervention. Participants are assessed at baseline, and 2 weeks and every 3 months following the intervention. The primary outcome measure in Aim 1 is the change in the Insomnia Severity Index (ISI) score at 6 months following intervention. Non-inferiority analysis will be used to compare the effectiveness of the two delivery methods, with a pre-specified margin. Results will be ascertained via intent to treat and per-protocol procedures. The investigators hypothesize that the change in ISI score following CBT-I by video teleconferencing will not be clinically inferior to that following in-person delivery. In Aim 2, VA and non-VA total healthcare costs are being collected to test whether average cost is lower for Veterans receiving CBT-I by video teleconferencing versus in-person care. Preference is being assessed by the EuroQol and Health Utilities Index 2. Differences in the ratio of cost and quality-adjusted life years saved between CBT-I by video teleconferencing and in-person encounter will be compared to test the hypothesis that video teleconferencing will have lower cost and equivalent outcomes. Aim 3 is assessing the effect of CBT-I on functional outcomes (Short Form-12, Work and Social Adjustment Scale), sleep quality (Pittsburgh Sleep Quality Index, sleep diary and wrist actigraphy), and PTSD severity (the non-sleep component of the PTSD Checklist-Military). The investigators hypothesize that these functional outcomes and sleep quality measures will improve following each method of CBT-I delivery and that CBT-I will improve non-sleep-related PTSD severity. The formative evaluation of the telemedicine delivery of CBT-I in Aim 4 is using qualitative (targeted focus groups with participants and therapist interviews) and quantitative measures (Work Alliance Inventory, Treatment Credibility Scale, attrition) that will help guide future implementation of CBT-I by video teleconferencing
Anticipated Findings: The investigators believe these results will demonstrate that: 1) Veterans in both CBT-I groups will have similar improvement in functional outcomes, and 2) treatment delivery by video teleconferencing will be more cost effective than in-person care. These findings should lead to wider acceptance of video teleconferencing, thereby increasing patient access to care and reducing treatment costs.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Philadelphia VA Medical Center, Philadelphia, PA
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
Veterans will have to meet the following inclusion criteria in order to be enrolled in this RCT:
- Men and women at least 18 years of age.
- Meet current DSM-IV-TR criteria for PTSD as determined by the Clinician Administered PTSD Scale (CAPS)
- Insomnia Severity Index score > 14, the commonly used threshold for clinical insomnia, with self-reported duration of insomnia >6 months.
- Ability to read and speak English (assessment instruments and therapy will be available only in English)
Exclusion Criteria:
Veterans will be excluded from participation if they meet any of the following exclusion criteria:
- Unable or unwilling to provide informed consent.
- Unwilling to participate in supervised group sessions at the community based outpatient clinic
- No telephone access or inability to return for follow-up testing.
- Individuals with an untreated sleep disorder [e.g., obstructive sleep apnea (apnea-hypopnea index 15 events/hr), periodic limb movement disorder (10 leg movements/hr of sleep with arousals), central sleep apnea ( 50% of apneas are central), Cheyne-Stokes respiration, obesity hypoventilation syndrome, and narcolepsy].
- A clinically unstable medical condition as defined by a new diagnosis or change in medical management in the previous 2 months.
- Evidence of substance dependence during the preceding twelve months. Evidence of "at risk" drinking behavior over the past month. Namely for men: more than 4 drinks on a given night, drinking on more than 3 nights a week, or more than 14 total drinks in a week; for women: more than 3 drinks in a given night, drinking on more than 3 nights a week, or more than 7 total drinks in a week.
- Individuals with bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia and other psychotic disorders as determined by the SCID questionnaire. A concurrent anxiety disorder or depressive disorder diagnosis will be allowed.
- Individuals with prominent current suicidal or homicidal ideation. This will be assessed by the clinical psychologist administering the SCID and CAPS. In cases of prominent current suicidal or homicidal ideation appropriate safety measures will be taken. Following stabilization, Veterans who continue to be interested in participating in the study may be re-assessed.
- Unable to perform tests due to inability to communicate verbally, inability to read and write; less than a 5th grade reading level; visual, hearing or cognitive impairment (e.g., previous head injury).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: CBT-I delivery by video teleconferencing
Groups of participants will receive a cognitive behavioral therapy for insomnia program delivered by a trained psychologist using video teleconferencing.
|
A behavioral modification program consisting of 6 clinic sessions focused on sleep hygiene, stimulus control, sleep restriction, and cognitive restructuring.
Andre navn:
|
|
Aktiv komparator: In-person CBT-I delivery
Groups of participants will receive a cognitive behavioral therapy for insomnia (CBT-I) program by meeting in-person with a trained psychologist.
|
A behavioral modification program consisting of 6 clinic sessions focused on sleep hygiene, stimulus control, sleep restriction, and cognitive restructuring.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change From Baseline in Insomnia Severity Index Score
Tidsramme: Baseline to 3 months
|
Self-report questionnaire used widely to assess presence of insomnia and its severity.
Scores range from 0-28.
Higher scores indicate increasing severity of insomnia.
|
Baseline to 3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change From Baseline PTSD Checklist-Military (PCL-M) Scores
Tidsramme: baseline to 3 months
|
Self-administered validated questionnaire measuring PTSD severity.
Scores range from 17-85.
Higher scores indicate higher severity of symptoms.
|
baseline to 3 months
|
|
Change From Baseline Pittsburgh Sleep Quality Index (PSQI) Scores
Tidsramme: baseline to 3 months
|
Self-administered validated questionnaire measuring subjective sleep quality.
Scores range from 0-21.
Higher score indicates worse sleep quality.
Total score < 5 is associated with good sleep quality.
|
baseline to 3 months
|
|
Change From Baseline in Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)
Tidsramme: baseline to 3 months
|
Measure of the sleep and dream disturbances often associated with PTSD.
Scores range from 0-21.
A higher score indicates higher frequency of disruptive nocturnal behaviors.
Total score ≥ 4 can be used to indicate PTSD.
|
baseline to 3 months
|
|
Change From Baseline in Nightmare Distress Questionnaire Scores
Tidsramme: baseline to 3 month
|
Measure of intensity of the distress associated with a nightmare.
Scores range from 0-52.
Higher score indicates increased nightmare distress.
|
baseline to 3 month
|
|
Change From Baseline Medical Outcomes Study Short Form-12 (SF-12) Mental Component Score
Tidsramme: baseline to 3 months
|
Self-administered validated general health-related quality of life questionnaire to assess functional outcome.
Scores range from 0 to 100.
Higher scores indicate higher health function.
|
baseline to 3 months
|
|
Change From Baseline in Medical Outcomes Study Short Form-12 (SF-12) Physical Component Score
Tidsramme: baseline to 3 months
|
self-administered validated health related quality of life questionnaire to assess functional outcomes.
Scores range from 0 to 100.
Higher scores indicate higher health function.
|
baseline to 3 months
|
|
Change From Baseline in Work and Social Adjustment Scale Scores
Tidsramme: baseline to 3 months
|
A self-report scale of functional impairment attributable to an identified problem.
Scores range from 0 - 40.
Higher scores indicate increasing functional impairment.
|
baseline to 3 months
|
|
Working Alliance Inventory - Short Revised (WAI-SR) - Task Formation Scores at 8 Weeks
Tidsramme: 2-8 weeks
|
The WAI-SR is a 12 item self report of patient's perceived quality of interaction with practitioner.
The scale focuses on task alliance, goal alliance, and bond formation.
Items range from 1- never to 7- always.
Scores range from 7-84.
Higher scores indicate better alliance.
Scores are reported from session 4.
|
2-8 weeks
|
|
Charleston Psychiatric Outpatient Satisfaction Scale-VA Scores at 8 Weeks
Tidsramme: 2-8 weeks
|
Self administered questionnaire of person's satisfaction with care.
Total scores range from 13 to 65, with higher scores indicating higher patient satisfaction.
Scores reported from session 5.
|
2-8 weeks
|
|
Change From Baseline in Nightmare Frequency Questionnaire (NFQ) Part 1 Scores
Tidsramme: baseline to 3 months, scores converted to yearly
|
Measure of nightmare frequency in number of nights with nightmares per year, scores converted to yearly.
|
baseline to 3 months, scores converted to yearly
|
|
Change From Baseline in Nightmare Frequency Questionnaire (NFQ) Part 2 Scores
Tidsramme: baseline to 3 months (converted to yearly)
|
Self-administered measure of nightmare frequency in actual number of nightmares experienced over a 3 month period, and converted to yearly
|
baseline to 3 months (converted to yearly)
|
|
Working Alliance Inventory - Short Revised (WAI-SR) - Bond Formation at 8 Weeks
Tidsramme: 2-8 weeks
|
The WAI-SR is a 12 item self report of patient's perceived quality of interaction with practitioner.
The scale focuses on task alliance, goal alliance, and bond formation.
Items range from 1- never to 7- always.
Scores range from 7-84.
Higher scores indicate better alliance.
Scores are reported from session 4.
|
2-8 weeks
|
|
Working Alliance Inventory - Short Revised (WAI-SR) - Goal Formation at 8 Weeks
Tidsramme: 2-8 weeks
|
The WAI-SR is a 12 item self report of patient's perceived quality of interaction with practitioner.
The scale focuses on task alliance, goal alliance, and bond formation.
Items range from 1- never to 7- always.
Scores range from 7-84.
Higher scores indicate better alliance.
Scores are reported from session 4.
|
2-8 weeks
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Samuel T. Kuna, MD, Philadelphia VA Medical Center, Philadelphia, PA
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- IIR 11-296
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .